NCT03730558View on ClinicalTrials.gov

ZETA : Prospective Observational Study

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

November 8, 2021

Study Completion Date

November 8, 2021

Conditions
Metastatic Colon Cancer
Interventions
COMBINATION_PRODUCT

aflibercept + FOLFIRI

aflibercept + FOLFIRI

Trial Locations (2)

84000

Institut Sainte-Catherine, Avignon

Institut Sainte Catherine, Avignon

All Listed Sponsors
lead

Recherche clinique

OTHER

NCT03730558 - ZETA : Prospective Observational Study | Biotech Hunter | Biotech Hunter